Arquivos do dia: Fevereiro 14, 2022
Nova Classificação Internacional de Doenças (CID-11) da OMS entra em vigor.
14 Fev, 2022 | 16:18hComunicado de imprensa: WHO’s new International Classification of Diseases (ICD-11) comes into effect – World Health Organization
Ver também:
Comentário no Twitter
🆕 The latest update for the 11th Revision of the International Classification of Diseases (ICD-11) is now online!#ICD11 is a 'common language' for health professionals to share standardized health information around the world.
Learn more https://t.co/M2yu9md9fm pic.twitter.com/jv2IbEkD5u— World Health Organization (WHO) (@WHO) February 11, 2022
Novavax afirma que vacina proteica funciona para crianças a partir dos 12 anos de idade.
14 Fev, 2022 | 16:16hNovavax says protein vaccine works for kids as young as 12 – Associated Press
Comunicado de imprensa: Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
Conteúdos relacionados:
Opinion | The mRNA vaccines are extraordinary, but Novavax is even better.
RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.
New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
Pfizer e FDA recuam em relação ao plano para agilizar a avaliação de vacinas contra Covid-19 em crianças menores de 5 anos.
14 Fev, 2022 | 16:14hPfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in young children – STAT
Ver também:
COVID-19 vaccine for kids under 5 delayed as Pfizer extends trial – CIDRAP
Pfizer postpones FDA request for Covid vaccine for kids under 5 – NBC News
Estudos conflitantes levantam questões sobre se algum anticorpo monoclonal funciona contra a variante “irmã” da Ômicron.
14 Fev, 2022 | 16:13hConteúdos relacionados:
FDA halts use of antibody drugs that don’t work vs. Omicron.
Diretriz ERS | Seguimento de “long COVID-19”.
14 Fev, 2022 | 16:11hEuropean Respiratory Society Statement on Long COVID-19 Follow-Up – European Respiratory Review
Primeira definição para “long Covid” em crianças e jovens é formalmente elaborada.
14 Fev, 2022 | 16:10hComunicado de imprensa: First research definition for ‘Long COVID’ in kids and young people formally agreed – BMJ
Artigo original (preprint): Long COVID (Post-COVID-19 condition) in Children: a modified Delphi Process – Archives of Disease in Childhood
Comentários:
Long covid: “Holistic” approach is best, given range of symptoms, say researchers – The BMJ
Conteúdos relacionados:
Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.
Review: Long COVID symptoms in children rarely persist beyond three months.
Covid-19: o que se sabe sobre as sublinhagens da Ômicron?
14 Fev, 2022 | 16:08hCovid-19: What do we know about omicron sublineages? – The BMJ
Conteúdos relacionados:
We regret to inform you that we are now discussing subvariants – Vox
Sudden rise of more transmissible form of Omicron catches scientists by surprise.
Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?
BA.2 is like Omicron’s sister. Here’s what we know about it so far – The Conversation
Comentário no Twitter
In November 2021 WHO designated omicron a variant of concern. With its sublineage BA.2 now widespread, @emahase_ looks at what science has found out about the variant and its three (so far) variations https://t.co/HjBZSwCATW
— The BMJ (@bmj_latest) February 13, 2022
Edição especial | Estratégias baseadas em evidências para melhor prescrição de antibióticos na atenção primária.
14 Fev, 2022 | 16:07hEditorial: Antibiotic stewardship – Australian Journal of General Practice
Evidence-based strategies for better antibiotic prescribing – Australian Journal of General Practice
Estudo randomizado | Profilaxia primária com norfloxacino evita infecções bacterianas em pacientes com insuficiência hepática crônica agudizada.
14 Fev, 2022 | 16:05hPrimary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial – The American Journal of Gastroenterology (link para o resumo – $ para o texto completo)